145 related articles for article (PubMed ID: 17957339)
1. A novel quinoline, MT477: suppresses cell signaling through Ras molecular pathway, inhibits PKC activity, and demonstrates in vivo anti-tumor activity against human carcinoma cell lines.
Jasinski P; Welsh B; Galvez J; Land D; Zwolak P; Ghandi L; Terai K; Dudek AZ
Invest New Drugs; 2008 Jun; 26(3):223-32. PubMed ID: 17957339
[TBL] [Abstract][Full Text] [Related]
2. PKC-alpha inhibitor MT477 slows tumor growth with minimal toxicity in in vivo model of non-Ras-mutated cancer via induction of apoptosis.
Jasinski P; Zwolak P; Terai K; Borja-Cacho D; Dudek AZ
Invest New Drugs; 2011 Feb; 29(1):33-40. PubMed ID: 19795097
[TBL] [Abstract][Full Text] [Related]
3. Novel Ras pathway inhibitor induces apoptosis and growth inhibition of K-ras-mutated cancer cells in vitro and in vivo.
Jasinski P; Zwolak P; Terai K; Dudek AZ
Transl Res; 2008 Nov; 152(5):203-12. PubMed ID: 19010291
[TBL] [Abstract][Full Text] [Related]
4. MT477 acts in tumor cells as an AURKA inhibitor and strongly induces NRF-2 signaling.
Jasinski P; Zwolak P; Terai K; Vogel RI; Borja-Cacho D; Dudek AZ
Anticancer Res; 2011 Apr; 31(4):1181-7. PubMed ID: 21508363
[TBL] [Abstract][Full Text] [Related]
5. Nobiletin induces inhibitions of Ras activity and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling to suppress cell proliferation in C6 rat glioma cells.
Aoki K; Yokosuka A; Mimaki Y; Fukunaga K; Yamakuni T
Biol Pharm Bull; 2013; 36(4):540-7. PubMed ID: 23546290
[TBL] [Abstract][Full Text] [Related]
6. R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation.
Caraglia M; Marra M; Leonetti C; Meo G; D'Alessandro AM; Baldi A; Santini D; Tonini G; Bertieri R; Zupi G; Budillon A; Abbruzzese A
J Cell Physiol; 2007 May; 211(2):533-43. PubMed ID: 17192846
[TBL] [Abstract][Full Text] [Related]
7. Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice.
Lin YJ; Zhen YS
Anticancer Drugs; 2009 Jan; 20(1):65-72. PubMed ID: 19343002
[TBL] [Abstract][Full Text] [Related]
8. MT103 inhibits tumor growth with minimal toxicity in murine model of lung carcinoma via induction of apoptosis.
Jasinski P; Zwolak P; Isaksson Vogel R; Bodempudi V; Terai K; Galvez J; Land D; Dudek AZ
Invest New Drugs; 2011 Oct; 29(5):846-52. PubMed ID: 20396929
[TBL] [Abstract][Full Text] [Related]
9. Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest.
Chan QK; Lam HM; Ng CF; Lee AY; Chan ES; Ng HK; Ho SM; Lau KM
Cell Death Differ; 2010 Sep; 17(9):1511-23. PubMed ID: 20203690
[TBL] [Abstract][Full Text] [Related]
10. Activation of protein kinase C betaII/epsilon-c-Jun NH2-terminal kinase pathway and inhibition of mitogen-activated protein/extracellular signal-regulated kinase 1/2 phosphorylation in antitumor invasive activity induced by the polymethoxy flavonoid, nobiletin.
Miyata Y; Sato T; Yano M; Ito A
Mol Cancer Ther; 2004 Jul; 3(7):839-47. PubMed ID: 15252145
[TBL] [Abstract][Full Text] [Related]
11. A new chemical inhibitor of angiogenesis and tumorigenesis that targets the VEGF signaling pathway upstream of Ras.
Desroches-Castan A; Quélard D; Demeunynck M; Constant JF; Dong C; Keramidas M; Coll JL; Barette C; Lafanechère L; Feige JJ
Oncotarget; 2015 Mar; 6(7):5382-411. PubMed ID: 25742784
[TBL] [Abstract][Full Text] [Related]
12. Guibitang, a traditional herbal medicine, induces apoptotic death in A431 cells by regulating the activities of mitogen-activated protein kinases.
Yim NH; Kim A; Liang C; Cho WK; Ma JY
BMC Complement Altern Med; 2014 Sep; 14():344. PubMed ID: 25241226
[TBL] [Abstract][Full Text] [Related]
13. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
14. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
[TBL] [Abstract][Full Text] [Related]
15. Isoquercitrin inhibits bladder cancer progression in vivo and in vitro by regulating the PI3K/Akt and PKC signaling pathways.
Chen F; Chen X; Yang D; Che X; Wang J; Li X; Zhang Z; Wang Q; Zheng W; Wang L; Wang X; Song X
Oncol Rep; 2016 Jul; 36(1):165-72. PubMed ID: 27177091
[TBL] [Abstract][Full Text] [Related]
16. siRNA blocking the RAS signalling pathway and inhibits the growth of oesophageal squamous cell carcinoma in nude mice.
Wang X; Zheng Y; Fan Q; Zhang X; Shi Y
Cell Biochem Funct; 2014 Dec; 32(8):625-9. PubMed ID: 25430959
[TBL] [Abstract][Full Text] [Related]
17. Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics.
Lang L; Shay C; Zhao X; Teng Y
J Exp Clin Cancer Res; 2017 Aug; 36(1):112. PubMed ID: 28830537
[TBL] [Abstract][Full Text] [Related]
18. Cetuximab inhibits gastric cancer growth in vivo, independent of KRAS status.
Shi M; Shi H; Ji J; Cai Q; Chen X; Yu Y; Liu B; Zhu Z; Zhang J
Curr Cancer Drug Targets; 2014; 14(2):217-24. PubMed ID: 24467518
[TBL] [Abstract][Full Text] [Related]
19. P7170, a novel inhibitor of mTORC1/mTORC2 and Activin receptor-like Kinase 1 (ALK1) inhibits the growth of non small cell lung cancer.
Venkatesha VA; Joshi A; Venkataraman M; Sonawane V; Bhatia D; Tannu P; Bose J; Choudhari S; Srivastava A; Pandey PK; Lad VJ; Sangana R; Ahmed T; Damre A; Deore V; Sahu B; Kumar S; Sharma S; Agarwal VR
Mol Cancer; 2014 Dec; 13():259. PubMed ID: 25466244
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.
Ambrosini G; Cheema HS; Seelman S; Teed A; Sambol EB; Singer S; Schwartz GK
Mol Cancer Ther; 2008 Apr; 7(4):890-6. PubMed ID: 18413802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
